Perricone MD has appointed Ron Fugate as its new Chief Executive Officer to lead the brand through its next stage of growth.
"We took considerable time to identify the right leader who will bring Perricone MD to the next level in this rapidly changing and dynamic advanced skincare market," said Lion Capital LLP Partner and Managing Director Mary Minnick.
Minnick continues, "We're excited and confident in Ron's ability to put the consumer first, and to serve as an agile decision-maker who will successfully continue to define and grow Perricone MD's holistic brand vision among our brand loyalists and new consumers alike."
Ron Fugate joins the Perricone MD team as a highly experienced CEO with a strong background in consumer-driven companies. He has led multiple private equity and family-owned mid-market CPG companies, taking them through transformational growth and subsequent successful sale to strategic acquirers.
"I'm incredibly honored to have been granted the opportunity to serve as the CEO of this iconic skincare brand," said Ron Fugate. "Perricone MD's assortment of powerful skincare solutions has a strong consumer reputation, and I look forward to identifying new ways to evolve and grow the brand to become even stronger. That will come from finding new ways to resonate with our target consumer, and by making the brand's health-centric proposition more relevant than ever."
Most recently, Ron served as CEO of Renew Life, a Swander Pace-backed provider of natural products for digestive health and led the brand through a $290 million sale to Clorox in May 2016.